SnagRx vs HealthRx: Compounded semaglutide from $69 vs $99
Quick verdict: SnagRx is the lower-cost annual prepaid option with a locked-in per-dose rate, while HealthRx starts higher on its 12-month prepaid plan and emphasizes clinician-directed medication choice. This article compares SnagRx vs HealthRx across price, pricing model commitments, pharmacy and shipping, clinician review, and regulatory notes.
Price and plan structure: $69 vs $99 starting points
SnagRx lists compounded semaglutide from $69/month on a 12-month plan and tirzepatide from $119/month on a 12-month plan; month-to-month rates are $99 and $149. HealthRx advertises semaglutide from $99/month on a 12-month prepaid semaglutide plan ($1,163 today; $1,188 at renewal) and tirzepatide plans starting at $179/month. Both providers state the lowest advertised monthly price requires a longer prepaid plan. SnagRx explicitly notes the $69 and $119 figures are the 12-month plan rates and that month-to-month is higher.
View HealthRx prepaid plan details
Pricing guarantees and dose changes
SnagRx advertises a price locked flat at every dose and at renewal; its marketing states the rate you enroll at does not rise as dose escalates. HealthRx states your plan price does not change when your dose does. Both therefore present stable pricing through titration on their plans, but SnagRx markets the lock explicitly as a core differentiator and notes the 12-month plan yields the lower advertised monthly rate.
Confirm SnagRx price-lock terms
Pharmacy, shipping, and turnaround
SnagRx names its US 503A partner pharmacies and states next-day UPS/FedEx shipping in temperature-controlled packaging, with clinician review typically within five hours and always within 24. HealthRx says its compounded medication is prepared in a licensed 503A pharmacy cleanroom and offers overnight cold shipping with tracked free shipping on every plan. Both present rapid shipping and cold-chain handling; SnagRx explicitly lists named partner pharmacies and gives a clinician review timeframe.
Clinician review and medication selection
SnagRx uses OpenLoop Health, a network of US-licensed clinicians that screen eligibility and conduct a post-checkout clinician meeting; OpenLoop clinicians retain the decision to prescribe compounded GLP-1s. HealthRx emphasizes that the clinician reviewing your file decides whether semaglutide or tirzepatide is the right fit, or whether neither is, meaning the medication is chosen by clinician judgment rather than by the customer selecting from a menu. Both require clinician determination and note that treatment is available only when a licensed clinician determines it is medically appropriate.
Regulatory and product status
Both providers offer compounded medications and include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. SnagRx states its compounded GLP-1s are produced in FDA-regulated facilities but reiterates they are not FDA-approved finished products. HealthRx similarly states compounded medication is not FDA-approved and is prepared per prescription in a licensed 503A pharmacy.
Comparison table: SnagRx vs HealthRx
| Criteria | SnagRx | HealthRx |
|---|---|---|
| Lowest advertised semaglutide price | $69/mo on 12-month plan | $99/mo on 12-month prepaid plan |
| Lowest advertised tirzepatide price | $119/mo on 12-month plan | $179/mo starting plan |
| Price behavior during titration | Price locked flat at every dose and renewal | Plan price does not change when dose changes |
| Pharmacy type | Named US 503A compounding pharmacies | Compounded in licensed 503A pharmacy cleanroom |
| Shipping | Next-day UPS/FedEx, temperature-controlled | Overnight cold shipping, tracked and free on plans |
| Clinician network | OpenLoop Health network; reviews typically within 5 hours | Clinician decides medication; availability subject to clinician review |
| Regulatory note | Compounded medications not FDA-approved | Compounded medications not FDA-approved |
Other notable differences
SnagRx highlights named partner pharmacies, LegitScript certification claims you can verify independently, and a stated clinician review timeframe typically within five hours. HealthRx highlights clinician-led medication selection and provides specific prepaid plan totals in its advertising. SnagRx also advertises full refund if prescription is declined and mentions a 6-month weight-loss guarantee with terms; HealthRx cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change. Where a provider makes specific outcome or guarantee claims, those are presented as the provider’s statements.
Check HealthRx clinician and plan terms
Start SnagRx enrollment and assessment
Final thoughts on SnagRx vs HealthRx
In a direct comparison, SnagRx offers a lower advertised 12-month semaglutide price and markets a price-lock across dose changes and renewals, plus named US 503A pharmacies and a stated clinician review timeframe. HealthRx advertises a higher starting prepaid price but emphasizes clinician determination of which medication is appropriate and provides overnight cold shipping with tracked delivery. Both use compounded medications that are not FDA-approved and both require clinician review.
Choose SnagRx if you prioritize the lowest advertised 12-month semaglutide rate and an explicit price lock across titration. Choose HealthRx if you prioritize clinician-directed medication choice with overnight cold-chain shipping and a prepaid plan that lists total and renewal amounts.